Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Current Leases: 2019-2025

Historic Current Leases for Puma Biotechnology (PBYI) over the last 7 years, with Sep 2025 value amounting to $2.5 million.

  • Puma Biotechnology's Current Leases fell 53.81% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 53.81%. This contributed to the annual value of $5.5 million for FY2024, which is 15.42% up from last year.
  • Per Puma Biotechnology's latest filing, its Current Leases stood at $2.5 million for Q3 2025, which was down 43.40% from $4.4 million recorded in Q2 2025.
  • Puma Biotechnology's Current Leases' 5-year high stood at $5.7 million during Q1 2025, with a 5-year trough of $2.5 million in Q3 2025.
  • For the 3-year period, Puma Biotechnology's Current Leases averaged around $4.7 million, with its median value being $4.8 million (2023).
  • In the last 5 years, Puma Biotechnology's Current Leases rose by 17.73% in 2021 and then plummeted by 53.81% in 2025.
  • Over the past 5 years, Puma Biotechnology's Current Leases (Quarterly) stood at $3.6 million in 2021, then increased by 15.84% to $4.1 million in 2022, then grew by 15.94% to $4.8 million in 2023, then increased by 15.42% to $5.5 million in 2024, then tumbled by 53.81% to $2.5 million in 2025.
  • Its Current Leases stands at $2.5 million for Q3 2025, versus $4.4 million for Q2 2025 and $5.7 million for Q1 2025.